ArticleJTCVS open2024

RBT-1 reduces blood product utilization in patients undergoing nonemergency coronary artery bypass grafting and/or valve surgery.

Charles A Mack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.